Search  in | Advanced
   Print  
 


Contact Us

 

The U.S. Biovigilance Network seeks hospital and blood collection facilities interested in contributing data and private sector partners to provide financial support.

 

Questions and expressions of interest should be directed to biovigilance@aabb.org.  

 

To those who want to participate, please complete the form below to confirm your commitment. Please return your completed form to:

 

Barbee Whitaker, Ph.D.

Director, Data and Special Programs

AABB

8101 Glenbrook Road

Bethesda, MD  20814

bwhitaker@aabb.org  

Phone: 301.215.6588

Fax: 301.907.6895

 

Hemovigilance Intent to Participate Form (MS Word, PDF)

 

A representative from AABB will contact you to finalize the details of your participation. Thank you for your continued leadership on behalf of this critical initiative.

 

Return to U.S. Biovigilance Network

Last modified on 2/10/2010 7:16:16 AM
What's New!
AABB Weekly Report - March 12, 2010
Details
National Hemovigilance Program Launches to Track Adverse Events Associated with Blood Transfusion
Details
AABB Statement on XMRV Task Force
Details
Updated Circular of Information for Cellular Therapy Products
Details
Association Bulletin #10-01 - Association Bulletin Listings
Details
Current U.S. Blood Supply is Adequate to Handle Demands Resulting from Earthquake in Haiti
Details
Emerging Infectious Disease Agents
Details
Study Highlights Implications Of Influenza Pandemics On Blood Supplies
Details
Cellular Therapies Subsections
Details
Association Bulletin #09-08 - ISBT 128 Conditional Accreditation Status
Details
AABB Launches Facebook Fan Page
Details